The vast majority of drugs are small molecules, thus considerable efforts have been focused upon optimized formulations in this area. Large molecules are gaining importance as viable drug candidates, prompting the Seeker to search for a partner to identify new formulations to solubilize and stabilize biologically active molecules for an extended period of time.
Not only is it necessary to demonstrate the efficacy of a compound, it is also crucial that the molecule does not cause any off-target side effects or induce toxicity (e.g. carcinogenicity, developmental toxicity, mutagenicity, neurotoxicity, reproductive toxicity). In order to facilitate testing, the Seeker is interested in identifying collaborative partners with expertise in the development of homogenous formulations for a variety of large molecules.
This is an electronic Request-for-Partners (eRFP) Challenge. The Solver will write a preliminary proposal (about 2-4 pages, including supporting non-confidential information and contact details) to be evaluated by the Seeker with a goal of establishing a collaborative partnership. Upon completion of the evaluation, the Seeker may contact selected Solvers directly to work out terms for a collaboration contract. The monetary value of the contract will vary depending on the amount of work to be delivered and the agreed time frame.
Awards:- Collaboration with Bayer
Deadline:- 17-12-2021
